KKR leads financing for Harvest Partners’ investment in Med-Metrix

NEW YORK - Investment firm KKR (NYSE:KKR), a $126.7 billion market cap financial powerhouse with a ’GOOD’ Financial Health score according to InvestingPro, announced Friday that its credit funds and accounts served as lead investors in a financing package supporting Harvest Partners’ growth investment in Med-Metrix, a provider of technology-enabled Revenue Cycle Management solutions for healthcare organizations.

Med-Metrix CEO Joseph Davi and his management team will continue to lead the company while maintaining significant ownership stakes. A&M Capital, the previous majority owner who acquired Med-Metrix in 2021 with financing from KKR, will retain a minority position and contribute additional capital in this transaction.

Founded in 2010 and headquartered in New Jersey, Med-Metrix delivers end-to-end and targeted Revenue Cycle Management services to health systems and physician groups across the United States through its proprietary technology platform.

"Our long-standing relationships with Med-Metrix, Harvest, and AMC allowed us to move quickly and with conviction to seamlessly deliver a scaled solution for this transaction," said Alexander Foreman, Managing Director at KKR, in the press release statement.

KKR Capital Markets also acted as Left Lead Arranger and Bookrunner for the transaction. Financial terms of the investment were not disclosed.

KKR (NYSE:KKR) sponsors investment funds focused on private equity, credit and real assets, while also offering capital markets and insurance solutions through its subsidiaries. Based on InvestingPro analysis, the company appears to be trading near its Fair Value, with 12+ additional exclusive insights available to subscribers through the comprehensive Pro Research Report.

In other recent news, KKR & Co LP announced its second-quarter 2025 earnings, reporting results that surpassed analysts’ expectations. The company achieved an adjusted earnings per share (EPS) of $1.18, exceeding the forecasted $1.13. Additionally, KKR’s revenue reached $1.86 billion, surpassing the anticipated $1.81 billion. Despite these positive earnings results, the stock saw a decline in pre-market trading. The stock closed at $150.43, reflecting a decrease from its previous close. These recent developments highlight KKR’s financial performance in the second quarter.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.